Bridger Management, LLC Wave Life Sciences Ltd. Transaction History

Bridger Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$19.17 - $27.4 $12.5 Million - $17.9 Million	-653,141 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$22.93 - $42.84 $5.87 Million - $11 Million	256,051 Added 64.48%	653,141 $17 Million
Q1 2019 May 15, 2019	BUY	$32.69 - $47.91 $2.8 Million - $4.11 Million	85,697 Added 27.52%	397,090 $15.4 Million
Q4 2018 Feb 14, 2019	SELL	$37.1 - $50.11 $3.88 Million - $5.24 Million	-104,582 Reduced 25.14%	311,393 $13.1 Million
Q3 2018 Nov 14, 2018	SELL	$36.35 - $55.2 $5.33 Million - $8.09 Million	-146,640 Reduced 26.06%	415,975 $20.8 Million
Q2 2018 Aug 14, 2018	BUY	$33.85 - $50.65 $1.46 Million - $2.19 Million	43,180 Added 8.31%	562,615 $21.5 Million
Q1 2018 May 15, 2018	BUY	$32.45 - $54.7 $5.89 Million - $9.93 Million	181,486 Added 53.7%	519,435 $20.8 Million
Q4 2017 Feb 14, 2018	BUY	$21.8 - $39.35 $1.03 Million - $1.85 Million	47,064 Added 16.18%	337,949 $11.9 Million
Q3 2017 Nov 14, 2017	BUY	$16.4 - $25.05 $4.77 Million - $7.29 Million	290,885	290,885 $6.33 Million

146

93M

33K

57.2K

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $738M
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Bridger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridger Management, LLC with notifications on news.